Vertex Pharmaceuticals | VRTX - Ordinary Share Capital

Stock Price
465.57
Daily Change
-6.44 -1.36%
Monthly
3.74%
Yearly
-3.46%
Q1 Forecast
455.43

Vertex Pharmaceuticals reported $254M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
AbbVie USD 1.77B 1.75B Jun/2025
Acadia Pharmaceuticals USD 168.71M 104K Sep/2025
Agios Pharmaceuticals USD 58.28M 241K Sep/2025
Alnylam Pharmaceuticals USD 131.79M 130.49M Sep/2025
Amgen USD 538M 300K Sep/2025
Arrowhead Research USD 135.7M 2.44M Sep/2025
Biogen USD 146.7M 200K Sep/2025
BioMarin Pharmaceutical USD 192.1M 97K Sep/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Gilead Sciences USD 1.24B 0 Sep/2025
Incyte USD 196.13M 2.01M Sep/2025
Insmed USD 212.58M 210.76M Sep/2025
Ionis Pharmaceuticals USD 161.14M 160.98M Sep/2025
J&J USD 2.41B 584K Sep/2025
Merck USD 2.49B 15.79M Sep/2025
Moderna USD 391M 2M Sep/2025
Neurocrine Biosciences USD 99.7M 700K Sep/2025
Novartis USD 1.94B 23.4M Jun/2025
Pfizer USD 5.69B 1000K Sep/2025
PTC Therapeutics USD 79.93M 554K Sep/2025
Regeneron Pharmaceuticals USD 105.3M 1.1M Sep/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
Sarepta Therapeutics USD 104.77M 7.06M Sep/2025
Ultragenyx Pharmaceutical USD 96.44M 88K Sep/2025
United Therapeutics USD 42.9M 42.1M Sep/2025
Vertex Pharmaceuticals USD 254M 2.29M Sep/2025